Atara Biotherapeutics announces 1-for-25 reverse stock split

Atara Biotherapeutics announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-25. The reverse stock split will become effective at 12:01 a.m. Eastern Time, on June 20. The company’s common stock will begin trading on a post-split basis at the market open on June 20. The reverse stock split is part of the company’s plan to regain compliance with the minimum bid price requirement of $1.00 per share required to maintain continued listing on Nasdaq, among other benefits.